Skip to main content

Practical Management of Patients Infected with Resistant Organisms: An Infection Control Perspective

  • Chapter
Antimicrobial Resistance

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 390))

Abstract

Antibiotic resistant bacteria first became a major concern during the 1950’s with the emergence and widespread dissemination of penicillin-resistant strains of Staphylococcus aureus. However, in the 1970s and early 1980s, multi-drug resistant Gram-negative bacilli became the major problem confronting hospital-based infectious diseases clinicians and infection control programs.1,2,3 More recently, methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci have emerged as major nosocomial pathogens.4,5,6 The emergence of multidrug resistant Gram-positive pathogens despite the use of accepted isolation procedures has prompted a reassessment of our approaches to infection control in the hospital setting. The purpose of this review is to discuss the epidemiology and prevention of resistant nosocomial pathogens, with emphasis on emerging Gram-positive pathogens.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. R.A. Weinstein, C. Nathan, R. Gruensfelder, and S.A. Kabins. Endemic aminoglycoside resistance in gram-negative bacilli: Epidemiology and mechanisms. J Infect Dis. 141: 338–345, 1981.

    Article  Google Scholar 

  2. D.R. Schaberg, C.E. Rubens, R.H. Alford, W.E. Farrar, W. Schaffner, and Z.A. McGee. Evolution of antimicrobial resistance and nosocomial infection. Am J Med. 70: 445–448, 1981.

    Article  PubMed  CAS  Google Scholar 

  3. W.E. Stamm, R.A. Weinstein, and R.E. Dixon. Comparison of endemic and epidemic nosocomial infections. Am J Med. 70: 393–397, 1981.

    Article  PubMed  CAS  Google Scholar 

  4. J.M. Boyce. Increasing prevalence of methicillin-resistant Staphylococcus aureus in the United States. Infect Control Hosp Epidemiol. 11: 639–642, 1990

    Article  PubMed  CAS  Google Scholar 

  5. A.L. Panlilio, Culver DH, Gaynes RP, et al. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975–1991. Infect Control Hosp Epidemiol. 13: 582–586, 1992.

    Article  PubMed  CAS  Google Scholar 

  6. T.R. Frieden, S.S. Munsiff, D.E. Low, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet. 342: 76–79, 1993.

    Article  PubMed  CAS  Google Scholar 

  7. R.A. Weinstein and S.A. Kabins. Strategies for prevention and control of multiple drug-resistant nosocomial infection. Am J Med. 70: 449–454, 1981

    PubMed  CAS  Google Scholar 

  8. J.S. Garner, W.R. Jarvis, T.G. Emori, T.C. Horan, and J.M. Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 16: 128–140, 1988.

    Article  PubMed  CAS  Google Scholar 

  9. P. Lynch, M.J. Cummings, P.L. Roberts, M.J. Herriott, B. Yates, and W.E. Stamm. Implementing and evaluating a system of generic infection precautions: body substance isolation. Am J Infect Control. 18: 1–12, 1990.

    Article  PubMed  CAS  Google Scholar 

  10. J.M. Boyce, S.M. Opal, J.W. Chow, et al. An outbreak of multi-drug resistant Enterococcus faecium with transferable variB class vancomycin resistance. J Clin Microbiol. 32: 1148–1153, 1994.

    PubMed  CAS  Google Scholar 

  11. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2–A4, M100–S3. National Committee for Clinical Laboratory Standards. Villanova, PA., 1991.

    Google Scholar 

  12. J.M. Swenson, B.C. Hill, and C. Thornsberry. Problems with the disk diffusion test for detection of vancomycin resistance in enterococci. J Clin Microbiol. 27: 2140–2142, 1989.

    PubMed  CAS  Google Scholar 

  13. J.M. Swenson, M.J. Ferraro, D.F. Sahm, P. Charache, and National Committee for Clinical Laboratory Standards Working Group on Enterococci, Tenover FC. New vancomycin disk diffusion breakpoints for enterococci. J Clin Microbiol. 30: 2525–2528, 1992.

    Google Scholar 

  14. K.S. Meyer, C. Urban, J.A. Eagan, B.J. Berger, and J.J. Rahal. Nosocomial outbreak of Klebs iella infection resistant to late-generation cephalosporins. Ann Intern Med. 119: 353–358, 1993.

    Article  PubMed  CAS  Google Scholar 

  15. R.N. Maslow, M.E. Mulligan, and R. D. Arbeit. Molecular epidemiology: application of contemporary techniques to the typing of microorganisms. Clin Infect Dis. 17: 153–164, 1993.

    Article  PubMed  CAS  Google Scholar 

  16. K.H. Kim, R. Fekety, D.H. Batts, et al. Isolation of Clostridium domicile from the environment and contacts of patients with antibioitic-associated colitis. J Infect Dis. 143: 42–50, 1981.

    Article  PubMed  CAS  Google Scholar 

  17. J.M. Boyce, G. Potter-Bynoe, C. Chevevert, and N.L. Hughes. Contamination of environmental surfaces with methicillin-resistant Staphylococcus aureus (MRSA): infection control implications. Presented at the Fourth Annual Meeting of the Society for Hospital Epidemiology of America, New Orleans, LA, March. (Abstract ), 1994.

    Google Scholar 

  18. J.M. Boyce, S.M. Opal, G. Potter-Bynoe, and A.A. Medeiros. Spread of methicillin-resistant Staphylococcus aureus in a hospital after exposure to a health care worker with chronic sinusitis. Clin Infect Dis. 17: 496–504, 1993.

    Article  PubMed  CAS  Google Scholar 

  19. R.P. Wenzel, M.D. Nettleman, R.N. Jones, and M.A. Pfaller. Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures. Am J Med. 91 (suppl 3B): 221S - 227S, 1991.

    Article  PubMed  CAS  Google Scholar 

  20. M.E. Mulligan, K.A. Murray-Leisure, B.S. Ribner, et al. Methicillin-resistant Staphylococcus aureus: A consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med. 94: 313–328, 1993.

    Article  PubMed  CAS  Google Scholar 

  21. J.M. Boyce, M.M. Jackson, G. Pugliese, el al. Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. Infect Control Hosp Epidemiol. 15: 105–115, 1994.

    Article  PubMed  CAS  Google Scholar 

  22. L.B. Rice, S.H. Willey, G.A. Papanicolaou, et al. Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother. 34: 2193–2199, 1990.

    Article  PubMed  CAS  Google Scholar 

  23. L. Naumovski, J.P. Quinn, D. Miyashiro, et al. Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients. Antimicrob Agents Chemother. 36: 1991–1996, 1992.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Boyce, J.M. (1995). Practical Management of Patients Infected with Resistant Organisms: An Infection Control Perspective. In: Jungkind, D.L., Mortensen, J.E., Fraimow, H.S., Calandra, G.B. (eds) Antimicrobial Resistance. Advances in Experimental Medicine and Biology, vol 390. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9203-4_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9203-4_15

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9205-8

  • Online ISBN: 978-1-4757-9203-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics